Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

CPIX Total Debt

Short-term and long-term borrowings combined.

Cumberland Pharmaceuticals Inc.NASDAQ: CPIX

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt falls 3.6% from a year ago

Total debt stood at $10.07M at the end of Q1 FY2026, down 3.6% from a year earlier and down 1.1% from the prior quarter. Over 3 fiscal years it compounded at -21.4% a year.

Context

  • Total debt amounted to 14.2% of total assets at the end of Q1 FY2026, down 0.7 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -3.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$10.07M-1.1% QoQ
Last fiscal yearDec 2025
$10.18M-50.5% YoY
Year agoMar 2025
$10.44M-3.6% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.6%——
1 year-50.5%——
3-year CAGR-21.4%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
10.18M USD
Year-over-year change
-50.5%
4-year CAGR
-10.8%

Total Debt vs competitors

How CPIX compares with its peers on the latest reported figures

  • CPIX's Mar 2026 total debt of $10.07M is the 2nd highest of the 4 companies compared; the peer median is $5.05M.
  • Its year-over-year change of -3.6% is the 2nd highest of 4, against a peer median of -40.6%.
  • Total debt amounts to 14.2% of total assets for CPIX, versus a peer median of 38.1%.
CPIX Competitors Peer median
Total Debt for CPIX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CELUCelularity Inc.Dec 2025$40.9M -40.6%-14.6%38.1%
CPIXCumberland Pharmaceuticals Inc.Mar 2026$10.07M -3.6%-21.4%14.2%
DYAIDyadic International, Inc.Mar 2026$5.05M -0.2%—64.7%
LTRNLantern Pharma Inc.Mar 2026$59.08K -69.7%+1040.9%0.8%
Peer median (excluding CPIX) $5.05M-40.6%+513.2%38.1%

Competitors are the stored peer set for CPIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents27.04M19.76M18.32M17.96M11.44M
Short-term Investments00000
Net Receivables6.88M13.16M9.76M11.7M16.94M
Inventory8.43M9.86M4.61M4M6.23M
Other Current Assets03.08M3.03M2.79M2.45M
Total Current Assets45.69M45.87M35.71M36.45M37.06M
Property, Plant & Equipment (Net)1.47M5.5M7.04M6.45M8.61M
Goodwill882K914K914K914K914K
Intangible Assets23.95M30.59M22.61M17.97M14.03M
Long-term Investments00003.99M
Tax Assets00000
Other Non-current Assets12.47M10.05M15.5M13.79M12.23M
Total Non-current Assets38.77M47.05M46.06M39.13M39.76M
Total Assets84.46M92.93M81.78M75.58M76.82M
Account Payables9.64M10.82M14.04M13.91M18.57M
Short-term Debt0005.1M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities5.96M13.57M10.79M10.18M14.92M
Total Current Liabilities19.28M28.58M27.98M31.62M36.74M
Long-term Debt15M16.2M12.78M10.18M5.24M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.49M7.59M6.45M6.3M5.82M
Total Non-current Liabilities22.58M28.37M24.53M21.42M15.53M
Total Liabilities41.86M56.95M52.52M53.04M52.28M
Common Stock48.45M47.47M47.09M46.82M51.68M
Retained Earnings(5.64M)(11.21M)(17.49M)(23.97M)(26.8M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest(212.33K)(292.13K)(343.57K)(307.52K)(336.1K)
Total Equity42.6M35.97M29.26M22.55M24.54M
Total Debt16.06M20.96M18.43M20.57M10.18M
Net Debt(10.98M)1.2M106.86K2.61M(1.26M)

Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Intrinsic Alpha fair value

Locked

Current Price

$6.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.